Physiologically Based Pharmacokinetic/Pharmacodynamic model of gastrointestinal toxicity induced by 5-fluorouracil in mouse and translation to human Poster Physiologically Based Pharmacokinetic/Pharmacodynamic model of gastrointestinal toxicity induced by 5-fluorouracil in mouse and translation to human CertaraSeptember 4, 2019
Use of a Physiologically based Pharmacokinetic – Pharmacodynamic Model to Account for Adjustments to dosing of S-warfarin in Different Populations Poster Use of a Physiologically based Pharmacokinetic – Pharmacodynamic Model to Account for Adjustments to dosing of S-warfarin in Different Populations CertaraSeptember 3, 2019
Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. Poster Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. CertaraSeptember 3, 2019
Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach Poster Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach CertaraSeptember 3, 2019
Modeling in vitro skin permeation experiments to mechanistically understand in vivo dermal absorption: Application of in vitro-in vivo extrapolation (IVIVE) and physiological based pharmacokinetic (PBPK) modeling using testosterone as model drug Poster Modeling in vitro skin permeation experiments to mechanistically understand in vivo dermal absorption: Application of in vitro-in vivo extrapolation (IVIVE) and physiological based pharmacokinetic (PBPK) modeling using testosterone as model drug CertaraSeptember 3, 2019
Assessing the Bioequivalence of Tacrolimus Amorphous Formulations with Varying Degrees of Crystallinity using Mechanistic Dissolution Models in a Population Physiologically-based Pharmacokinetic (PBPK) Modelling Framework Poster Assessing the Bioequivalence of Tacrolimus Amorphous Formulations with Varying Degrees of Crystallinity using Mechanistic Dissolution Models in a Population Physiologically-based Pharmacokinetic (PBPK) Modelling Framework CertaraSeptember 3, 2019
Application of Feto-Placental-Maternal Physiologically-based Pharmacokinetic Model to Predict Tenofovir Concentration during Pregnancy Poster Application of Feto-Placental-Maternal Physiologically-based Pharmacokinetic Model to Predict Tenofovir Concentration during Pregnancy CertaraSeptember 3, 2019
Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect Poster Development of a Physiologically Based Pharmacokinetic Model of Buspirone and Its Active Metabolite 1-(2-Pyrimidinyl)-Piperazine to Estimate Drug-Drug Interaction and Food Effect CertaraSeptember 3, 2019
Physiologically-based pharmacokinetic modeling of the effect of chronic kidney disease on the pharmacokinetics of drugs eliminated nonrenally Poster Physiologically-based pharmacokinetic modeling of the effect of chronic kidney disease on the pharmacokinetics of drugs eliminated nonrenally CertaraSeptember 3, 2019
A comparison of two model reduction methodologies for a QSP bone biology system with denosumab dosing Poster A comparison of two model reduction methodologies for a QSP bone biology system with denosumab dosing CertaraSeptember 3, 2019
